Fresh Funds For Trials Of Novartis’s Novel Malaria Combo In Africa

 
• By Ian Schofield

New funding has been provided for more trials of Novartis’s combination malaria treatment in west and central Africa, adding to ongoing efforts to tackle the disease on the continent. 

Malaria
More funding has been awarded for antimalarial trials in Africa • Source: Shutterstock

More from Clinical Trials

More from R&D